Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News REGENXBIO and Nippon Shinyaku collaborate on transformative gene therapies for MPS disorders In a significant move for the treatment of rare genetic diseases, REGENXBIO Inc. has entered an exclusive partnership… byPallavi MadhirajuJanuary 14, 2025